Revolution Medicines Billion Market: Why the Valuation Makes Sense
A biotech with no current revenue can still carry a sky-high valuation. This article explains how Revolution Medicine...
Index level data represents a snapshot of market values at a given time. This explanation covers how levels are computed and used in analysis.
24,561 articlesA biotech with no current revenue can still carry a sky-high valuation. This article explains how Revolution Medicine...
NTREIS taps Joey Bandemer to spearhead data governance and customer experience, part of a broader modernization effor...
In this in-depth piece, we explore Mamoon Hamid’s approach to AI investing at Kleiner Perkins, the lessons from early...
A July data center power surge is lifting select U.S.-listed industrials. Here’s a fresh look at the stocks riding th...
AI sparks a data deluge, and storage stocks ride the wave. This guide breaks down how this storage stock more opportu...
AI progress hinges not just on GPUs but on the speed and efficiency of data delivery. This deep dive explains why opt...
Zillow, Compass, and MRED filed competing post-hearing briefs after a two-day Chicago hearing on data feeds. A judge ...
The hype around SpaceX often drowns out solid opportunities in AI-powered space companies. This guide shines a light ...
Daré (DARE) has a developing pipeline and a tight cash runway. This article breaks down what the Q4 2025 earnings cal...
Small, nearly unknown biotech stocks can surge when their pipeline milestones hit. This guide breaks down how to spot...
A new breed of data firms is staking its future on owning compute. This land data startup is buying GPUs and mapping ...
Two AI powerhouses are forming a rare alliance to chase a massive market. This article explains the rationale, potent...